⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5654080 | 0.97 | — | — | |
| SCHEMBL7630825 | 0.87 | LMNA (0.31) | — | |
| SCHEMBL5088191 | 0.87 | P2RX7 (0.35) | — | |
| SCHEMBL7636902 | 0.84 | LMNA (0.32) | — | |
| SCHEMBL7567494 | 0.84 | LMNA (0.34) | — | |
| SCHEMBL5085686 | 0.83 | LMNA (0.32) | — | |
| SCHEMBL7632646 | 0.83 | LMNA (0.31) | — | |
| SCHEMBL5088765 | 0.82 | — | — | |
| SCHEMBL5085679 | 0.79 | RAB9A (0.32) | — | |
| SCHEMBL5085350 | 0.79 | P2RX7 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1487886-B1 | SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-08-06 | — | — | EP | disclosed |
| US-7098356-B2 | Substituted indenyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-08-29 | — | — | US | disclosed |
| US-20050143536-A1 | Substituted indenyl metal complexes and polymerization process | DOW GLOBAL TECHNOLOGIES LLC | 2005-06-30 | — | — | US | disclosed |
| EP-1487886-A1 | SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | Dow Global Technologies Inc. (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2003078483-A1 | SUBSTITUTED INDENYL METAL COMPLEXES AND POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-09-25 | — | — | WO | disclosed |